IREB2 and myelodysplastic syndrome: Consistent with this notion, a published microarray data set revealed that an increased IRP2 mRNA abundance in CD34+ hematopoietic progenitor cells was related to reduced survival in MDS patients without deletion of chromosome 5q (ref. 29) (Fig. 9f).